Evidence map›Paper›PMID 27058227›Full record

ArticleBlood cancer journal2016

Myeloproliferative neoplasm with eosinophilia and T-lymphoblastic lymphoma with ETV6-LYN gene fusion.

N Telford, S Alexander, O J McGinn, M Williams, K M Wood, A Bloor, V Saha

Abstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Myeloid/Lymphoid Neoplasms withJournal of inflammation research · 2023
    Article
  6. Case Report: Identification of a novelFrontiers in oncology · 2023
    Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

N TelfordOncology Cytogenetics, The Christie Pathology Partnership, The Christie NHS Foundation Trust, Manchester, UK.
S AlexanderChildren's Cancer Group, Centre for Paediatric, Teenage and Young Adult Cancer, Institute of Cancer, University of Manchester, Manchester, UK.
O J McGinnChildren's Cancer Group, Centre for Paediatric, Teenage and Young Adult Cancer, Institute of Cancer, University of Manchester, Manchester, UK.
M WilliamsLeukaemia Biology Group, Institute of Cancer, University of Manchester, Manchester, UK.
K M WoodDepartment of Cellular Pathology, Royal Victoria Infirmary, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
A BloorHaematology and Transplant Unit, The Christie NHS Foundation Trust, Manchester, UK.
V SahaChildren's Cancer Group, Centre for Paediatric, Teenage and Young Adult Cancer, Institute of Cancer, University of Manchester, Manchester, UK.

Funding

Cancer Research UK 14840Medical Research Council
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic Combined Chemotherapy ProtocolsDisease ProgressionEosinophiliaETS Translocation Variant 6 ProteinFatal OutcomeHumansMaleMiddle AgedMyeloproliferative DisordersOncogene Proteins, FusionPrecursor T-Cell Lymphoblastic Leukemia-LymphomaProto-Oncogene Proteins c-etsRepressor Proteinssrc-Family KinasesETS Translocation Variant 6 Proteinlyn protein-tyrosine kinaseOncogene Proteins, FusionProto-Oncogene Proteins c-etsRepressor Proteinssrc-Family Kinases

Identifiers

PMID27058227
PMCPMC4855251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.